Renal Function Decline Under Therapy With Small Interfering RNA Silencing ALAS1 for Acute Intermittent Porphyria-Reference-Cited by-同舟云学术

Renal Function Decline Under Therapy With Small Interfering RNA Silencing ALAS1 for Acute Intermittent Porphyria

Published:2021-07 Issue:7 Volume:6 Page:1904-1911
ISSN:2468-0249
Container-title:Kidney International Reports
language:en
Short-container-title:Kidney International Reports

Author:

Lazareth Hélène,Poli Antoine,Bignon Yohan,Mirmiran Arienne,Rabant Marion,Cohen Raphaël,Schmitt Caroline,Puy Hervé,Karras Alexandre,Gouya Laurent,Pallet Nicolas

Publisher

Elsevier BV

Subject

Nephrology

Reference9 articles.

1. Porphyria;Bissell;N Engl J Med,2017

2. Porphyrias;Puy;Lancet,2010

3. Pharmacokinetics and pharmacodynamics of the small interfering ribonucleic acid, givosiran, in patients with acute hepatic porphyria;Agarwal;Clin Pharmacol Ther,2020

4. RNAi-mediated silencing of hepatic Alas1 effectively prevents and treats the induced acute attacks in acute intermittent porphyria mice;Yasuda;Proc Natl Acad Sci U S A,2014

5. Phase 1 Trial of an RNA interference therapy for acute intermittent porphyria;Sardh;N Engl J Med,2019

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Givosiran for the Treatment of Pediatric Acute Intermittent Porphyria;Journal of Pediatric Hematology/Oncology;2024-08-22

2. Cosmic kidney disease: an integrated pan-omic, physiological and morphological study into spaceflight-induced renal dysfunction;Nature Communications;2024-06-11

3. Preventing hyperhomocysteinemia using vitamin B6 supplementation in Givosiran-treated acute intermittent porphyria: Highlights from a case report and brief literature review;Molecular Genetics and Metabolism Reports;2024-06

4. Évolution thérapeutique dans la porphyrie aiguë intermittente : place du givosiran;La Revue de Médecine Interne;2024-06

5. Long‐term complications in acute porphyria;Liver International;2024-05-31